Article
Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography.
BMC genetics - 1 Jan 2001
Le Maréchal C, Chen J M, Quéré I, Raguénès O, Férec C, Auroux J
Abstract excerpt
BACKGROUND: R122, the primary autolysis site of the human cationic trypsinogen (PRSS1), constitutes an important "self-destruct" or "fail-safe" defensive mechanism against premature trypsin activation within the pancreas. Disruption of this site by a missense mutation, R122H, was found to cause hereditary pancreatitis. In addition to a c.365G>A (CGC>CAC) single nucleotide substitution, a c.365 through 366GC>AT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.